Status
Conditions
Study type
Funder types
Identifiers
About
We hypothesized that the number of circulating tumor cells (CTCs) and molecular markers on CTCs could be a prognostic factor or predictive factor to patients with head neck cancer.
Full description
Histologically or cytopathologically proven head and neck squamous cell carcinoma (HNSCC)
Disease status: locally advanced or recurrent/metastasized at initial presentation
Age >=20 years old
Could understand and signed the informed consents of this study
Enrolled patients were classified into three distinct subgroups:
Blood samples were collected within 7 days before the first dose of chemotherapy.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Ability to sign informed consent.
Exclusion criteria
Inability to comply with study and/or follow-up procedures.
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal